Boai NKY Pharmaceuticals Ltd
Boai NKY Medical Holdings Ltd. engages in the fine chemical and precision medicine businesses in China and internationally. The company produces and sells polyvinyl pyrrolidone (PVP), Orarez, and in vitro diagnostic products, as well as invests in tumor drugs. It offers its products for pharmaceutical products, such as APIs and excipients; personal care products, including cosmetics, haircare, or… Read more
Boai NKY Pharmaceuticals Ltd (300109) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.038x
Based on the latest financial reports, Boai NKY Pharmaceuticals Ltd (300109) has a cash flow conversion efficiency ratio of 0.038x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥139.46 Million) by net assets (CN¥3.69 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Boai NKY Pharmaceuticals Ltd - Cash Flow Conversion Efficiency Trend (2007–2024)
This chart illustrates how Boai NKY Pharmaceuticals Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Boai NKY Pharmaceuticals Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Boai NKY Pharmaceuticals Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Forehope Electronic (Ningbo) Co. Ltd. A
SHG:688362
|
N/A |
|
Hyundai Construction Equipment Co Ltd
KO:267270
|
0.045x |
|
Harrow Health Inc
NASDAQ:HROW
|
0.356x |
|
Tikehau Capital
PINK:TKKHF
|
-0.143x |
|
Shandong Dongyue Organosilicon Mat
SHE:300821
|
0.023x |
|
InterRent Real Estate Investment Trust
PINK:IIPZF
|
0.009x |
|
Chongqing Three Gorges Water Conservancy and Electric Power Co Ltd
SHG:600116
|
0.048x |
|
Mercialys
PINK:MEIYF
|
0.127x |
Annual Cash Flow Conversion Efficiency for Boai NKY Pharmaceuticals Ltd (2007–2024)
The table below shows the annual cash flow conversion efficiency of Boai NKY Pharmaceuticals Ltd from 2007 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥3.61 Billion | CN¥256.03 Million | 0.071x | -48.84% |
| 2023-12-31 | CN¥3.52 Billion | CN¥488.25 Million | 0.139x | +71.74% |
| 2022-12-31 | CN¥3.12 Billion | CN¥251.77 Million | 0.081x | +532.17% |
| 2021-12-31 | CN¥3.40 Billion | CN¥43.44 Million | 0.013x | -85.27% |
| 2020-12-31 | CN¥3.08 Billion | CN¥266.87 Million | 0.087x | +232.53% |
| 2019-12-31 | CN¥3.05 Billion | CN¥79.64 Million | 0.026x | -31.79% |
| 2018-12-31 | CN¥1.28 Billion | CN¥48.81 Million | 0.038x | +5.36% |
| 2017-12-31 | CN¥1.30 Billion | CN¥47.28 Million | 0.036x | -60.99% |
| 2016-12-31 | CN¥1.23 Billion | CN¥114.14 Million | 0.093x | +68.78% |
| 2015-12-31 | CN¥1.16 Billion | CN¥64.12 Million | 0.055x | -52.64% |
| 2014-12-31 | CN¥400.25 Million | CN¥46.60 Million | 0.116x | +89.44% |
| 2013-12-31 | CN¥377.06 Million | CN¥23.17 Million | 0.061x | +8.28% |
| 2012-12-31 | CN¥363.81 Million | CN¥20.65 Million | 0.057x | +405.33% |
| 2011-12-31 | CN¥350.93 Million | CN¥3.94 Million | 0.011x | -62.77% |
| 2010-12-31 | CN¥333.21 Million | CN¥10.05 Million | 0.030x | -93.44% |
| 2009-12-31 | CN¥62.14 Million | CN¥28.57 Million | 0.460x | +593.63% |
| 2008-12-31 | CN¥43.93 Million | CN¥-4.09 Million | -0.093x | -117.36% |
| 2007-12-31 | CN¥17.82 Million | CN¥9.56 Million | 0.536x | -- |